ArticleIn silico pharmacology2021

Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study.

Reza Nejat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.